Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 12.10% vs -7.66% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 11.51% vs -30.09% in Mar 2025
Interest
No Interest in the last few periods;
Profit After Tax
YoY Growth in year ended Mar 2026 is 6.44% vs -14.16% in Mar 2025
Compare Profit and Loss Results of Amwill Health
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
45.00
75.00
-30.00
-40.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
45.00
75.00
-30.00
-40.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
1.00
-1.00
-100.00%
Raw Materials Consumed
0.00
27.00
-27.00
-100.00%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
8.00
17.00
-9.00
-52.94%
Operating Expenses
13.00
0.00
13.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7.00
5.00
2.00
40.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
3.00
-3.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
32.00
66.00
-34.00
-51.52%
Operating Profit (PBDIT) excl Other Income
12.00
9.00
3.00
33.33%
Other Income
2.00
1.00
1.00
100.00%
Operating Profit (PBDIT)
15.00
10.00
5.00
50.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
15.00
10.00
5.00
50.00%
Depreciation
0.00
3.00
-3.00
-100.00%
Profit Before Taxation & Exceptional Items
15.00
7.00
8.00
114.29%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
15.00
6.00
9.00
150.00%
Provision for Tax
3.00
1.00
2.00
200.00%
Profit After Tax
11.00
4.00
7.00
175.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
12.00
8.00
4.00
50.00%
Profit Available for appropriations
23.00
13.00
10.00
76.92%
Appropriations
23.00
13.00
10.00
76.92%
Equity Dividend (%)
5%
35%
-30.00
Earnings Per Share
5.71
40.28
-34.57
-85.82%
Profit And Loss - Net Sales
Net Sales 45.49 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.10% vs -7.66% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.99 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.51% vs -30.09% in Mar 2025
Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2026Figures in Cr
No Interest in the last few periods;
Profit And Loss - Profit After Tax
Profit After Tax 11.42 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.44% vs -14.16% in Mar 2025
